LEHI, Utah and LOUISVILLE, Ky., May 29, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named a 2025–2026 Best Company to Work For by U.S. News & World Report. In addition to this national honor, U.S. News & World Report also named Waystar a Best Company to Work For in both the Health Care and Research sector and the West region.U.S. News & World Report evaluated the 5,000 largest public companies based on employee sentiment across s ...

SALT LAKE CITY, May 29, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that members of the Sera team will participate in the following upcoming investor conferences:William Blair 45th Annual Growth Stock ConferenceDate: June 3 – 5, 20251X1 Meetings OnlyDoug Fisher, M.D., Strategic Advisor to Sera and former Chief Business Offic ...

GE HealthCare Technologies (GEHC) FY 2025 Annual General Meeting May 28, 2025 10:00 AM ET Speaker0 At GE Healthcare, we believe the future of healthcare has no limits and that it will be defined not by how to treat an illness, but by how to treat the patient. The future of healthcare will combine AI with clinician expertise to create a cohesive view of each patient from millions of points of data. It will use advanced imaging to diagnose in minutes. It will make care more predictive and therapies more preci ...

Investor Presentation FIRST QUARTER | FISCAL YEAR 2026 Forward Looking Statements This presentation includes express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operational performance and may contain projections of our future results o ...

Core Insights - Life Time has announced a partnership with Kiehl's to enhance member wellness experiences through the introduction of Kiehl's skincare products in its athletic country clubs in Manhattan and Brooklyn [1][2][4] Company Overview - Life Time operates 180 athletic country clubs across the United States and Canada, focusing on healthy living and wellness for individuals aged 90 days to over 90 years [9] - Kiehl's, a brand under L'Oréal USA, has a rich history as an apothecary founded in 1851, known for its effective skincare products developed through extensive research and customer feedback [10] Product Offerings - Members at Life Time will have exclusive access to Kiehl's popular products, including Amino Acid Shampoo, Form 133 Conditioner, Grapefruit Body Wash, and Crème de Corps, specifically selected for their effectiveness in pre- and post-workout routines [4][5] - The Kiehl's products will be available in dressing rooms and club showers, providing members with a moment of indulgence as part of their wellness routine [4] Marketing and Promotion - Kiehl's will implement various marketing initiatives to increase awareness, including features in Life Time's Experience Life Magazine, in-club digital assets, and member communications [7] Wellness Focus - The partnership aims to elevate the overall wellness experience, aligning with Life Time's commitment to providing immersive experiences that support members' healthy lifestyles [5][6] - Life Time's 2025 wellness survey indicated that over 80% of respondents dedicate several days a week to self-care activities [5]

Core Insights - McKesson (MCK) and Cardinal Health (CAH) are major players in the U.S. healthcare distribution sector, benefiting from consistent demand and long-term industry trends [1][2] - Investors are evaluating which company presents a stronger investment opportunity amid evolving healthcare regulations and inflationary pressures [2] Financial Performance - McKesson reported Q4 fiscal 2025 adjusted EPS of $10.12, exceeding the Zacks Consensus Estimate of $9.81 by 3.2%, with a year-over-year improvement of 63.8% [3] - Cardinal Health reported Q3 fiscal 2025 adjusted EPS of $2.35, surpassing the Zacks Consensus Estimate of $2.15 by 9.3%, with a year-over-year increase of 12.4% [4] Estimates Comparison - The Zacks Consensus Estimate for McKesson's fiscal 2026 sales and EPS indicates a year-over-year improvement of 12.4% and 12.3%, respectively, with EPS estimates improving by 1.4% over the past 60 days [5] - The Zacks Consensus Estimate for Cardinal Health's 2025 sales suggests a year-over-year decline of 1.7%, while EPS is expected to improve by 7.8%, with EPS estimates increasing by 2.3% over the past 30 days [8] Strategic Positioning - McKesson's diversification into higher-margin areas such as oncology and biopharma services supports margin stability and positions the company well for future growth [11] - McKesson's recent earnings report highlighted solid revenue growth, stable margins, and robust free cash flow, alongside consistent shareholder returns through share repurchases and dividend increases [12] - Cardinal Health is focusing on efficiency gains and cost controls while expanding its higher-growth medical segment, which is expected to drive growth [15] - Cardinal Health's first-quarter performance showed strong revenue growth and improving profitability due to effective cost-saving initiatives [16] Price Performance - Year-to-date, McKesson shares have increased by 25.7%, while Cardinal Health shares have surged by 29.2%, driven by rising demand for drug retailing, particularly GLP-1 drugs [17] Investment Outlook - Both companies currently hold a Zacks Rank 3 (Hold), complicating the investment decision [18] - McKesson's style score of 'A' indicates strong growth prospects and attractive valuation, while Cardinal Health's style score of 'C' reflects attractive valuation but lower growth potential [19] - Based on growth estimates and style scores, McKesson is viewed as a better investment choice at present [19]

Core Viewpoint - Syra Health Corp. has been recommended for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site, valued at $5.8 million over three years, with a potential one-year extension [1][2]. Company Overview - Syra Health is a healthcare technology company focused on improving health through innovative technology products and services, particularly in mental health, population health, and healthcare workforce [4]. - The company emphasizes prevention, access, and affordability in its healthcare solutions, aiming to advance healthcare nationwide and globally [4]. Contract Details - The contract with the Indiana Department of Administration involves Syra Health serving as the statewide access point for families and providers in the Child Mental Health Wraparound program [3]. - Syra Health will subcontract 23.5% of the total contract value to other Indiana-based companies, indicating a commitment to local partnerships [1]. Strategic Importance - This initiative is part of Indiana's broader strategy to enhance care coordination and improve mental health outcomes for children across the state [3]. - Syra Health has a proven track record of executing complex health initiatives for state and local governments, showcasing its capability in delivering comprehensive health solutions [2].

Financial Data and Key Metrics Changes - Second quarter revenue reached $2.64 billion, exceeding expectations, with a 9% sequential increase and a 22% year-over-year growth [19][22] - Gross margin was 69.4%, up 60 basis points sequentially, driven by higher utilization [21] - Operating margin was 41.2%, with operating expenses at $744 million, an increase of $57 million sequentially [22][23] - EPS was $1.85, up 32% year-over-year, surpassing the high end of the guided range [22] Business Line Data and Key Metrics Changes - Industrial segment accounted for 44% of revenue, up 8% sequentially and 17% year-over-year, with strong growth in aerospace and defense [19] - Automotive represented 32% of revenue, with a record result showing a 16% sequential increase and 24% year-over-year growth, driven by demand in China [20] - Communications made up 12% of revenue, increasing 5% sequentially and 32% year-over-year, with strong growth in wireline and data center [20] - Consumer segment also represented 12% of revenue, remaining flat sequentially but up 30% year-over-year [21] Market Data and Key Metrics Changes - Bookings grew sequentially across all end markets and geographies, with a backlog entering Q3 higher than the previous quarter [26] - The automotive market saw a notable increase in sales, particularly in North America and Europe, attributed to tariff-related pull-in activity [31][32] - Industrial automation showed positive book-to-bill ratios, indicating continued growth despite tariff uncertainties [45][47] Company Strategy and Development Direction - The company is focusing on five key megatrends: autonomy, proactive healthcare, energy transition and sustainability, immersive experience, and AI-driven computing and connectivity [13][14] - Significant investments in CapEx have been made to enhance manufacturing capabilities and supply chain resilience [12][19] - The company aims to balance lean channel inventories with higher levels of inventory on its balance sheet to support recovery [23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that revenues bottomed in 2024 and are returning to growth in fiscal 2025 [11][12] - The operating environment remains volatile due to tariff situations, but the company is optimistic about demand across its product portfolio [11][25] - Future guidance for Q3 expects revenue of approximately $2.75 billion, with industrial and consumer segments leading growth [26][27] Other Important Information - The company celebrated its 60th anniversary, a milestone achieved by fewer than 1% of public companies [17] - Free cash flow over the trailing twelve months was $3.3 billion, representing 34% of revenue, with nearly $2.5 billion returned to shareholders [24] Q&A Session Summary Question: What is driving the strong growth in automotive? - Management noted that Q2 was stronger than expected, with bookings and turns higher than normal, aided by pull-in activity around tariff announcements [30][31] Question: How much under shipping demand is the company experiencing? - Management estimated that they are shipping about 10% below end consumption, with expectations to normalize in Q3 [39] Question: What is the outlook for industrial automation? - Management reported continued growth in industrial automation, with positive book-to-bill ratios across all subsectors [45][47] Question: How is the company addressing supply chain and foundry diversity? - The company has significantly increased its internal capacity and is focusing on a flexible approach between internal and external manufacturing [93][95] Question: What are the expectations for SAAR and auto builds in the second half of the year? - Management expects SAAR to decline in the second half, but anticipates continued growth in content to offset some of that pressure [74]

Financial Data and Key Metrics Changes - Second quarter revenue reached $2.64 billion, exceeding expectations, with a 9% sequential increase and a 22% year-over-year growth [16] - Gross margin was 69.4%, up 60 basis points sequentially, driven by higher utilization [18] - Operating margin was 41.2%, with EPS at $1.85, reflecting a 32% year-over-year increase [19] - Free cash flow over the trailing twelve months was $3.3 billion, or 34% of revenue [21] Business Line Data and Key Metrics Changes - Industrial segment accounted for 44% of revenue, up 8% sequentially and 17% year-over-year [16] - Automotive segment represented 32% of revenue, with a 16% sequential increase and 24% year-over-year growth, driven by strong demand in China [17] - Communications segment made up 12% of revenue, increasing 5% sequentially and 32% year-over-year, with strong growth in wireline and data center [18] - Consumer segment also represented 12% of revenue, remaining flat sequentially but up 30% year-over-year [18] Market Data and Key Metrics Changes - Strong growth observed in aerospace and defense and automated test equipment (ATE) within the industrial market [16] - Automotive demand in North America and Europe increased by approximately 20% sequentially due to tariff-related pull-in activity [28] - Overall bookings grew sequentially across all end markets and geographies, with a backlog entering Q3 higher than the previous quarter [22] Company Strategy and Development Direction - Company is focusing on five key megatrends: autonomy, proactive healthcare, energy transition and sustainability, immersive experience, and AI-driven computing and connectivity [10] - Significant investments in capital expenditures to enhance and scale hybrid manufacturing models, expanding capacity in the US and Europe [9] - Emphasis on delivering complete solutions to customers, leveraging extensive product portfolio and technological expertise [11] Management's Comments on Operating Environment and Future Outlook - Management believes revenue bottomed in 2024 and is returning to growth in fiscal 2025, supported by favorable demand trends [8] - The company is maintaining a strategy of balancing lean channel inventories with higher levels of inventory on the balance sheet [20] - Management expects third quarter revenue to be approximately $2.75 billion, with industrial and consumer segments leading growth [22] Other Important Information - The company celebrated its 60th anniversary, a milestone achieved by fewer than 1% of public companies [14] - Management highlighted the importance of adapting to business transitions early and focusing capital investments to maximize value [9] Q&A Session Summary Question: What is driving the strong growth in automotive? - Management noted that Q2 was stronger than expected, with bookings and turns significantly higher, aided by pull-in activity related to tariffs [28] Question: How much is the company under shipping demand currently? - Management estimated that they are shipping approximately 10% below end consumption, with expectations to normalize in Q3 [36] Question: What is the outlook for industrial automation? - Management reported continued growth in industrial automation, with positive book-to-bill ratios across all subsectors [41] Question: How is the company addressing supply chain and foundry diversity? - The company has increased internal capacity significantly and is also partnering with external foundries to ensure flexibility and resilience [92]

Ingersoll Rand (IR) FY Conference Summary Company Overview - **Company**: Ingersoll Rand (IR) - **Event**: FY Conference held on May 22, 2025 - **Key Speaker**: Vik Kinney, SVP and CFO Key Points Company Transformation and Performance - Ingersoll Rand has undergone significant transformation since the merger five years ago, including two major divestitures and over 65 acquisitions, creating a resilient platform in the ITS and PST business segments [3][4] - The company has demonstrated resilience through various challenges, including COVID-19 and market uncertainties, maintaining operational effectiveness [5][6] Recent Financial Performance - In Q1, Ingersoll Rand reported approximately 3% organic orders momentum across both ITS and PST segments, marking the first positive trend in several quarters [7][8] - The company observed good momentum in both short and long cycle projects, with leading indicators such as MQLs showing low double-digit growth [9][10] - April's performance continued to align with expectations, indicating sustained order growth [11] Market Conditions and Guidance - Despite ongoing market uncertainties, the company remains optimistic about order momentum and backlog for the second quarter and the remainder of the year [10][19] - The guidance for the year was adjusted to reflect a more prudent approach, with a reduction in organic volume expectations by about four points, while still anticipating a positive trajectory in the second half of the year [18][19] Tariffs and Pricing Strategy - The company expects tariff pricing to offset costs, estimating a $150 million impact, which translates to a 2% revenue uptick in revised guidance [14][15] - Foreign exchange (FX) and mergers and acquisitions (M&A) are also contributing to revenue tailwinds, with FX providing a 1.5% boost and M&A contributing an additional 0.5% [17] Supply Chain and Regional Strategy - Ingersoll Rand continues to operate on a region-for-region basis, with 98% of its China business supplying within the region, minimizing reliance on external sourcing [30][32] - The company is exploring opportunities for supply chain optimization, including potential sourcing shifts to regions like Eastern Europe and India [30][32] Long Cycle Projects and Customer Engagement - The company has not seen a dramatic pause in long cycle projects, with approximately 20-25% of its original equipment business being longer cycle in nature [35][36] - Healthy project momentum is expected to continue into Q2 and the latter half of the year, with ongoing engagement with customers in various regions [38][41] Services and Recurring Revenue Model - Ingersoll Rand is transitioning its service model from traditional break-fix to a CARE model, which involves risk transfer agreements with customers, providing a more stable revenue stream [44][47] - The CARE model is expected to enhance customer satisfaction and generate higher gross margins, with aspirations to reach a billion-dollar revenue base by 2027 [53][56] M&A Activity - The company has completed six acquisitions year-to-date, with a focus on smaller bolt-on deals, and has nine additional letters of intent (LOIs) in progress [66][70] - The ILC Dover acquisition is showing positive momentum, particularly in the life sciences sector, with operational improvements and healthy order momentum [71][73] Additional Insights - The company is optimistic about the potential for margin expansion, particularly in the PST segment, which is expected to lead in margin growth moving forward [63] - Ingersoll Rand is committed to investing in its platforms and optimizing its operations to drive future growth and profitability [72][73]